Improved PFS and OS With Ixazomib Plus Lenalidomide-Dexamethasone (IRd) vs Placebo-Rd in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Final Data From the Phase 3 China Continuation of TOURMALINE-MM1
Title:
Improved PFS and OS With Ixazomib Plus Lenalidomide-Dexamethasone (IRd) vs Placebo-Rd in Patients (pts) With Relapsed/Refractory Multiple Myeloma (RRMM): Final Data From the Phase 3 China Continuation of TOURMALINE-MM1
Author:
Hou, Jian Jin, Jie Xu, Yan Wu, Depei Ke, Xiaoyan Daobin, Zhou Lu, Jin Du, Xin Chen, Xiequn Li, Junmin Liu, Jing Gupta, Neeraj Hanley, Michael Li, Hongmei Hua, Zhaowei Wang, Bingxia Zhang, Xiaoquan Wang, Hui van de Velde, Helgi Richardson, Paul Moreau, Philippe